Tarsus Pharmaceuticals Inc (TARS) — Free Cash Flow Generation Index

Latest as of December 2025: 0.67x

Tarsus Pharmaceuticals Inc (TARS) has a Free Cash Flow Generation Index of 0.67x as of December 2025. Free cash flow of $12.97 Million represents 1% of operating cash flow ($19.33 Million). See how liquid is Tarsus Pharmaceuticals Inc's working capital to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.67x
Free Cash Flow / Operating CF

Free Cash Flow

$12.97 Million
USD

Operating Cash Flow

$19.33 Million
USD

Capital Expenditures

$6.36 Million
USD

Tarsus Pharmaceuticals Inc Free Cash Flow Generation Index (2021–2021)

Historical FCF Generation Index trend for Tarsus Pharmaceuticals Inc across 1 annual periods. Explore Tarsus Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Tarsus Pharmaceuticals Inc (2021–2021)

Year-by-year Free Cash Flow Generation Index for Tarsus Pharmaceuticals Inc. For the full company profile including market capitalisation, see Tarsus Pharmaceuticals Inc market cap and net worth.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2021 0.84x $3.16 Million $3.75 Million $586.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).